# Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail)

> **NCT03072550** · NA · COMPLETED · sponsor: **DeviceFarm, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Onychomycosis Due to Trichophyton Rubrum
- Onychomycosis Due to Trichophyton Mentagrophytes

## Interventions

- **DEVICE:** RenewalNail™ Plasma Treatment System

## Key facts

- **NCT ID:** NCT03072550
- **Lead sponsor:** DeviceFarm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-06-30
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-09-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03072550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03072550, "Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03072550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*